Cargando…
Oncolytic Vaccinia Virus Harboring Aphrocallistes vastus Lectin Inhibits the Growth of Cervical Cancer Cells Hela S3
Aphrocallistes vastus lectin (AVL) is a C-type marine lectin produced by sponges. Our previous study demonstrated that genes encoding AVL enhanced the cytotoxic effect of oncolytic vaccinia virus (oncoVV) in a variety of cancer cells. In this study, the inhibitory effect of oncoVV-AVL on Hela S3 cer...
Autores principales: | Ni, Jiajun, Feng, Hualin, Xu, Xiang, Liu, Tingting, Ye, Ting, Chen, Kan, Li, Gongchu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537278/ https://www.ncbi.nlm.nih.gov/pubmed/34677432 http://dx.doi.org/10.3390/md19100532 |
Ejemplares similares
-
Oncolytic Vaccinia Virus Harboring Aphrocallistes vastus Lectin Inhibits the Growth of Hepatocellular Carcinoma Cells
por: Jiang, Riqing, et al.
Publicado: (2022) -
Oncolytic Vaccinia Virus Expressing Aphrocallistes vastus Lectin as a Cancer Therapeutic Agent
por: Wu, Tao, et al.
Publicado: (2019) -
Oncolytic Vaccinia Virus Carrying Aphrocallistes vastus Lectin (oncoVV-AVL) Enhances Inflammatory Response in Hepatocellular Carcinoma Cells
por: Zheng, Xinnan, et al.
Publicado: (2022) -
Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells
por: Zhou, Yanrong, et al.
Publicado: (2023) -
A Comparative Study of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins in Breast Cancer Cells
por: Zhou, Yanrong, et al.
Publicado: (2023)